Drugs / IL3 CAR T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04599543 | Nov 2020 → Nov 2023 overdue | acute myeloid leukemia | Zhejiang University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL3 CAR T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04599543 ↗ |
| Known as | IL3 CAR-T cells injection | “IL3 CAR-T cells injection” NCT04599543 ↗ |
| Modality | Cell therapy | “IL3 CAR T-cell Therapy” NCT04599543 ↗ |